Therapeutic Nuclear Medicine Market Size, Share, Growth, and Industry Analysis, By Type (Radium-223, Iodine-131, Leutitium-177, Yttrium-90, Samarium-153, Strontium-89, Rhenium-188+Rhenium-186, Erbium- 169, Phosphorous-32, Others), By Application (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Therapeutic Nuclear Medicine Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Therapeutic Nuclear Medicine Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Therapeutic Nuclear Medicine Business Mode and Production Process
2.3.1 Therapeutic Nuclear Medicine Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Therapeutic Nuclear Medicine Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Therapeutic Nuclear Medicine
2.4.2 Raw Material Cost of Therapeutic Nuclear Medicine
2.4.3 Labor Cost of Therapeutic Nuclear Medicine
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Therapeutic Nuclear Medicine Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Therapeutic Nuclear Medicine Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Therapeutic Nuclear Medicine Price by Manufacturer (2021-2026)
4.4 Therapeutic Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Therapeutic Nuclear Medicine, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Therapeutic Nuclear Medicine, Product Offered and Application
4.7 Therapeutic Nuclear Medicine Market Competitive Situation and Trends
4.7.1 Therapeutic Nuclear Medicine Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Therapeutic Nuclear Medicine Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Therapeutic Nuclear Medicine Market Historical Development by Geographic Region (2021-2026)
5.1 Global Therapeutic Nuclear Medicine Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Therapeutic Nuclear Medicine Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Therapeutic Nuclear Medicine Market Status by Country (2021-2026)
5.3.1 North America Therapeutic Nuclear Medicine Sales Volume by Country (2021-2026)
5.3.2 North America Therapeutic Nuclear Medicine Revenue by Country (2021-2026)
5.3.3 United States Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Therapeutic Nuclear Medicine Market Status by Country (2021-2026)
5.4.1 Europe Therapeutic Nuclear Medicine Sales Volume by Country (2021-2026)
5.4.2 Europe Therapeutic Nuclear Medicine Revenue by Country (2021-2026)
5.4.3 Germany Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Therapeutic Nuclear Medicine Market Status by Country (2021-2026)
5.5.1 Asia Pacific Therapeutic Nuclear Medicine Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Therapeutic Nuclear Medicine Revenue by Country (2021-2026)
5.5.3 China Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Therapeutic Nuclear Medicine Market Status by Country (2021-2026)
5.6.1 Latin America Therapeutic Nuclear Medicine Sales Volume by Country (2021-2026)
5.6.2 Latin America Therapeutic Nuclear Medicine Revenue by Country (2021-2026)
5.6.3 Mexico Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Therapeutic Nuclear Medicine Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Therapeutic Nuclear Medicine Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Therapeutic Nuclear Medicine Revenue by Country (2021-2026)
5.7.3 GCC Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Therapeutic Nuclear Medicine Sales Volume, Revenue and Growth (2021-2026)

6 Global Therapeutic Nuclear Medicine Market Historical Development by Product Type (2021-2026)
6.1 Therapeutic Nuclear Medicine Definition by Type
6.2 Global Therapeutic Nuclear Medicine Historical Sales Volume by Product Type (2021-2026)
6.3 Global Therapeutic Nuclear Medicine Historical Revenue by Product Type (2021-2026)
6.4 Global Therapeutic Nuclear Medicine Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Radium-223 (2021-2026)
6.5.2 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Iodine-131 (2021-2026)
6.5.3 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Leutitium-177 (2021-2026)
6.5.4 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Yttrium-90 (2021-2026)
6.5.5 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Samarium-153 (2021-2026)
6.5.6 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Strontium-89 (2021-2026)
6.5.7 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Rhenium-188+Rhenium-186 (2021-2026)
6.5.8 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Erbium- 169 (2021-2026)
6.5.9 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Phosphorous-32 (2021-2026)
6.5.10 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

7 Global Therapeutic Nuclear Medicine Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Therapeutic Nuclear Medicine Historical Sales Volume by End User (2021-2026)
7.3 Global Therapeutic Nuclear Medicine Historical Revenue by End User (2021-2026)
7.4 Global Therapeutic Nuclear Medicine Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Ambulatory Surgical Centers (2021-2026)
7.5.3 Global Therapeutic Nuclear Medicine Historical Sales Volume, Revenue and Growth Rate of Cancer Research Institutes (2021-2026)

8 Leading Companies Profiles
8.1 International Isotopes Idaho, Inc.
8.1.1 International Isotopes Idaho, Inc. Corporation Information
8.1.2 International Isotopes Idaho, Inc. - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.1.3 International Isotopes Idaho, Inc. Performance Analysis (2021-2026)
8.1.4 International Isotopes Idaho, Inc. Business and Markets Served
8.1.5 International Isotopes Idaho, Inc. Recent Developments
8.2 Bracco Imaging S.p.A
8.2.1 Bracco Imaging S.p.A Corporation Information
8.2.2 Bracco Imaging S.p.A - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.2.3 Bracco Imaging S.p.A Performance Analysis (2021-2026)
8.2.4 Bracco Imaging S.p.A Business and Markets Served
8.2.5 Bracco Imaging S.p.A Recent Developments
8.3 Medi-Radiopharma Co., Ltd.
8.3.1 Medi-Radiopharma Co., Ltd. Corporation Information
8.3.2 Medi-Radiopharma Co., Ltd. - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.3.3 Medi-Radiopharma Co., Ltd. Performance Analysis (2021-2026)
8.3.4 Medi-Radiopharma Co., Ltd. Business and Markets Served
8.3.5 Medi-Radiopharma Co., Ltd. Recent Developments
8.4 Cardinal Health Inc.
8.4.1 Cardinal Health Inc. Corporation Information
8.4.2 Cardinal Health Inc. - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.4.3 Cardinal Health Inc. Performance Analysis (2021-2026)
8.4.4 Cardinal Health Inc. Business and Markets Served
8.4.5 Cardinal Health Inc. Recent Developments
8.5 Lantheus Medical Imaging Inc.
8.5.1 Lantheus Medical Imaging Inc. Corporation Information
8.5.2 Lantheus Medical Imaging Inc. - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.5.3 Lantheus Medical Imaging Inc. Performance Analysis (2021-2026)
8.5.4 Lantheus Medical Imaging Inc. Business and Markets Served
8.5.5 Lantheus Medical Imaging Inc. Recent Developments
8.6 Mallinckrodt plc.
8.6.1 Mallinckrodt plc. Corporation Information
8.6.2 Mallinckrodt plc. - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.6.3 Mallinckrodt plc. Performance Analysis (2021-2026)
8.6.4 Mallinckrodt plc. Business and Markets Served
8.6.5 Mallinckrodt plc. Recent Developments
8.7 Eckert & Ziegler
8.7.1 Eckert & Ziegler Corporation Information
8.7.2 Eckert & Ziegler - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.7.3 Eckert & Ziegler Performance Analysis (2021-2026)
8.7.4 Eckert & Ziegler Business and Markets Served
8.7.5 Eckert & Ziegler Recent Developments
8.8 Bayer AG
8.8.1 Bayer AG Corporation Information
8.8.2 Bayer AG - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.8.3 Bayer AG Performance Analysis (2021-2026)
8.8.4 Bayer AG Business and Markets Served
8.8.5 Bayer AG Recent Developments
8.9 GE Healthcare
8.9.1 GE Healthcare Corporation Information
8.9.2 GE Healthcare - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.9.3 GE Healthcare Performance Analysis (2021-2026)
8.9.4 GE Healthcare Business and Markets Served
8.9.5 GE Healthcare Recent Developments
8.10 Curium Pharma
8.10.1 Curium Pharma Corporation Information
8.10.2 Curium Pharma - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.10.3 Curium Pharma Performance Analysis (2021-2026)
8.10.4 Curium Pharma Business and Markets Served
8.10.5 Curium Pharma Recent Developments
8.11 Novartis AG
8.11.1 Novartis AG Corporation Information
8.11.2 Novartis AG - Therapeutic Nuclear Medicine Product Portfolio and Specification
8.11.3 Novartis AG Performance Analysis (2021-2026)
8.11.4 Novartis AG Business and Markets Served
8.11.5 Novartis AG Recent Developments

9 Global Therapeutic Nuclear Medicine Market Forecast by Product Type and End User (2026-2034)
9.1 Global Therapeutic Nuclear Medicine Market Forecast by Product Type (2026-2034)
9.1.1 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Radium-223 (2026-2034)
9.1.2 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Iodine-131 (2026-2034)
9.1.3 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Leutitium-177 (2026-2034)
9.1.4 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Yttrium-90 (2026-2034)
9.1.5 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Samarium-153 (2026-2034)
9.1.6 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Strontium-89 (2026-2034)
9.1.7 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Rhenium-188+Rhenium-186 (2026-2034)
9.1.8 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Erbium- 169 (2026-2034)
9.1.9 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Phosphorous-32 (2026-2034)
9.1.10 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global Therapeutic Nuclear Medicine Market Forecast by End User (2026-2034)
9.2.1 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2034)
9.2.2 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Ambulatory Surgical Centers (2026-2034)
9.2.3 Global Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth Rate of Cancer Research Institutes (2026-2034)

10 Global Therapeutic Nuclear Medicine Market Forecast by Geographic Region (2026-2034)
10.1 Global Therapeutic Nuclear Medicine Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Therapeutic Nuclear Medicine Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer